Literature DB >> 19483103

Sex differences in the expression of hepatic drug metabolizing enzymes.

David J Waxman1, Minita G Holloway.   

Abstract

Sex differences in pharmacokinetics and pharmacodynamics characterize many drugs and contribute to individual differences in drug efficacy and toxicity. Sex-based differences in drug metabolism are the primary cause of sex-dependent pharmacokinetics and reflect underlying sex differences in the expression of hepatic enzymes active in the metabolism of drugs, steroids, fatty acids and environmental chemicals, including cytochromes P450 (P450s), sulfotransferases, glutathione transferases, and UDP-glucuronosyltransferases. Studies in the rat and mouse liver models have identified more than 1000 genes whose expression is sex-dependent; together, these genes impart substantial sexual dimorphism to liver metabolic function and pathophysiology. Sex differences in drug metabolism and pharmacokinetics also occur in humans and are due in part to the female-predominant expression of CYP3A4, the most important P450 catalyst of drug metabolism in human liver. The sexually dimorphic expression of P450s and other liver-expressed genes is regulated by the temporal pattern of plasma growth hormone (GH) release by the pituitary gland, which shows significant sex differences. These differences are most pronounced in rats and mice, where plasma GH profiles are highly pulsatile (intermittent) in male animals versus more frequent (nearly continuous) in female animals. This review discusses key features of the cell signaling and molecular regulatory mechanisms by which these sex-dependent plasma GH patterns impart sex specificity to the liver. Moreover, the essential role proposed for the GH-activated transcription factor signal transducer and activator of transcription (STAT) 5b, and for hepatic nuclear factor (HNF) 4alpha, as mediators of the sex-dependent effects of GH on the liver, is evaluated. Together, these studies of the cellular, molecular, and gene regulatory mechanisms that underlie sex-based differences in liver gene expression have provided novel insights into the physiological regulation of both xenobiotic and endobiotic metabolism.

Entities:  

Mesh:

Year:  2009        PMID: 19483103      PMCID: PMC2713118          DOI: 10.1124/mol.109.056705

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  203 in total

Review 1.  Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics.

Authors:  Gail D Anderson
Journal:  J Womens Health (Larchmt)       Date:  2005 Jan-Feb       Impact factor: 2.681

Review 2.  Epigenetic regulation by histone methylation and histone variants.

Authors:  Peter Cheung; Priscilla Lau
Journal:  Mol Endocrinol       Date:  2005-01-27

3.  Hypothalamic STAT proteins: regulation of somatostatin neurones by growth hormone via STAT5b.

Authors:  E Bennett; L McGuinness; E F Gevers; G B Thomas; I C A F Robinson; H W Davey; S M Luckman
Journal:  J Neuroendocrinol       Date:  2005-03       Impact factor: 3.627

4.  Gender-specific alterations in gene expression and loss of liver sexual dimorphism in the long-lived Ames dwarf mice.

Authors:  Daniel Amador-Noguez; John Zimmerman; Susan Venable; Gretchen Darlington
Journal:  Biochem Biophys Res Commun       Date:  2005-07-15       Impact factor: 3.575

5.  Novel gender-related regulation of CYP2C12 gene expression in rats.

Authors:  Megumi Endo; Yoshiki Takahashi; Yasumasa Sasaki; Tetsuya Saito; Tetsuya Kamataki
Journal:  Mol Endocrinol       Date:  2005-01-20

Review 6.  The influence of age and sex on the clearance of cytochrome P450 3A substrates.

Authors:  Monette M Cotreau; Lisa L von Moltke; David J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

7.  Identification of a distal STAT5-binding DNA region that may mediate growth hormone regulation of insulin-like growth factor-I gene expression.

Authors:  Ying Wang; Honglin Jiang
Journal:  J Biol Chem       Date:  2005-01-27       Impact factor: 5.157

8.  In vivo analysis of growth hormone receptor signaling domains and their associated transcripts.

Authors:  Jennifer E Rowland; Agnieszka M Lichanska; Linda M Kerr; Mary White; Elisabetta M d'Aniello; Sheryl L Maher; Richard Brown; Rohan D Teasdale; Peter G Noakes; Michael J Waters
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

9.  Role of hepatocyte nuclear factors in transcriptional regulation of male-specific CYP2A2.

Authors:  Christopher A Wiwi; David J Waxman
Journal:  J Biol Chem       Date:  2004-11-10       Impact factor: 5.157

10.  Gender difference in serum bisphenol A levels may be caused by liver UDP-glucuronosyltransferase activity in rats.

Authors:  Toru Takeuchi; Osamu Tsutsumi; Naohito Nakamura; Yumiko Ikezuki; Yasushi Takai; Tetsu Yano; Yuji Taketani
Journal:  Biochem Biophys Res Commun       Date:  2004-12-10       Impact factor: 3.575

View more
  230 in total

1.  Gender differences in pharmacokinetics of maintenance dosed buprenorphine.

Authors:  David E Moody; Wenfang B Fang; Jerdravee Morrison; Elinore McCance-Katz
Journal:  Drug Alcohol Depend       Date:  2011-04-23       Impact factor: 4.492

2.  Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces.

Authors:  Jian-feng Xing; Hai-sheng You; Ya-lin Dong; Jun Lu; Si-ying Chen; Hui-fang Zhu; Qian Dong; Mao-yi Wang; Wei-hua Dong
Journal:  Acta Pharmacol Sin       Date:  2011-04-25       Impact factor: 6.150

3.  Epigenetic mechanisms involved in developmental nutritional programming.

Authors:  Anne Gabory; Linda Attig; Claudine Junien
Journal:  World J Diabetes       Date:  2011-10-15

4.  Liver-specific ablation of Krüppel-associated box-associated protein 1 in mice leads to male-predominant hepatosteatosis and development of liver adenoma.

Authors:  Karolina Bojkowska; Fabio Aloisio; Marco Cassano; Adamandia Kapopoulou; Francesca Santoni de Sio; Nadine Zangger; Sandra Offner; Cristina Cartoni; Charles Thomas; Simon Quenneville; Kai Johnsson; Didier Trono
Journal:  Hepatology       Date:  2012-08-27       Impact factor: 17.425

5.  Intrinsic sexually dimorphic expression of the principal human CYP3A4 correlated with suboptimal activation of GH/glucocorticoid-dependent transcriptional pathways in men.

Authors:  Chellappagounder Thangavel; Ettickan Boopathi; Bernard H Shapiro
Journal:  Endocrinology       Date:  2011-09-27       Impact factor: 4.736

6.  Unbiased, genome-wide in vivo mapping of transcriptional regulatory elements reveals sex differences in chromatin structure associated with sex-specific liver gene expression.

Authors:  Guoyu Ling; Aarathi Sugathan; Tali Mazor; Ernest Fraenkel; David J Waxman
Journal:  Mol Cell Biol       Date:  2010-09-27       Impact factor: 4.272

7.  RNA-sequencing quantification of hepatic ontogeny and tissue distribution of mRNAs of phase II enzymes in mice.

Authors:  Hong Lu; Sumedha Gunewardena; Julia Y Cui; Byunggil Yoo; Xiao-bo Zhong; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2013-02-04       Impact factor: 3.922

8.  Effect of Gender on the Pharmacokinetics of ON 123300, A Dual Inhibitor of ARK5 and CDK4/6 for the Treatment of Cancer, in Rats.

Authors:  Jennypher Mudunuru; Chen Ren; David R Taft; Manoj Maniar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-08       Impact factor: 2.441

9.  Sex-Differential Responses of Tumor Promotion-Associated Genes and Dysregulation of Novel Long Noncoding RNAs in Constitutive Androstane Receptor-Activated Mouse Liver.

Authors:  Nicholas J Lodato; Tisha Melia; Andy Rampersaud; David J Waxman
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

10.  Zinc Fingers and Homeoboxes 2 (Zhx2) Regulates Sexually Dimorphic Cyp Gene Expression in the Adult Mouse Liver.

Authors:  Kate T Creasy; Jieyun Jiang; Hui Ren; Martha L Peterson; Brett T Spear
Journal:  Gene Expr       Date:  2016-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.